Zimmer Biomet Holdings (ZBH) Change in Accured Expenses (2009 - 2026)

Zimmer Biomet Holdings' Change in Accured Expenses history runs 18 years deep, the most recent figure standing at -$183.0 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 402.75% year-over-year to -$183.0 million in Q1 2026; TTM through Mar 2026 was -$44.8 million, a 81.26% increase from a year earlier, with the FY2025 full-year figure at $101.8 million, up 131.61% from the prior year.
• Change in Accured Expenses declined to -$183.0 million in Q1 2026 per ZBH's latest filing, from $112.9 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $164.2 million in Q4 2023 and bottomed at -$183.0 million in Q1 2026.
• The 5-year median for Change in Accured Expenses is -$34.3 million (2023), against an average of -$20.9 million.
• Across the five-year window, Change in Accured Expenses slumped 477.36% in 2023 and surged 223.67% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at $104.6 million in 2022, then soared by 56.98% to $164.2 million in 2023, then plunged by 171.44% to -$117.3 million in 2024, then jumped by 196.25% to $112.9 million in 2025, then plunged by 262.09% to -$183.0 million in 2026.
• Per Business Quant, the three latest ZBH Change in Accured Expenses figures stand at -$183.0 million (Q1 2026), $112.9 million (Q4 2025), and -$51.5 million (Q3 2025).